September 1st, 2020 (Lure, France) – Vetoquinol confirms the completion of the acquisition of Profender® and Drontal® product families for the European Economic Area and the UK. This acquisition is effective from August 1st, 2020.
Vetoquinol has acquired the Profender® and Drontal® product families, the intellectual property, registrations and other rights previously owned by Bayer AG’s animal health business. The Profender® and Drontal® families of products are spot-on and tablet de-wormer products for cats and dogs.
Vetoquinol’s acquisition of Profender® and Drontal® is related to Elanco’s acquisition of Bayer AG’s animal health business, which was finalized on August 1st 2020.
Matthieu Frechin, CEO of Vetoquinol, said "We are extremely pleased to share the completion of the acquisition of the Profender® and Drontal® product lines. These two strong brands fit perfectly at the core of Vetoquinol strategy. From now on, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. Also, effective immediately, these products and brands strengthen our portfolio of Essentials, the engine of our growth. I am proud of the Vetoquinol teams who made this deal happen despite the challenging circumstances brought by the global COVID outbreak.”
Latest news of vetoquinol
2020 SALES: €427.5M (UP 8.0% AS REPORTED, UP 10.9% AT CONSTANT EXCHANGE RATE) ESSENTIALS SALES: €220.6M (UP 15.7% AS REPORTED, UP 17.3% AT CONSTANT EXCHANGE RATE)21 Jan 2021Vetoquinol CEO Matthieu Frechin said: “2020 was an exceptional year on a number of counts. Above all, it is important to pay tribute to our teams,...
ORION ANIMAL HEALTH AND VETOQUINOL EXPAND COLLABORATION - VETOQUINOL TO DISTRIBUTE ORION’S CLEVOR® IN THE USA AND ORION TO DISTRIBUTE DRONTAL® AND PROFENDER® PRODUCTS IN FINLAND, HUNGARY AND ROMANIA18 Jan 2021Orion Animal Health and Vetoquinol are expanding their collaboration with new distribution agreements.